{"id":{"repo_id":"vilnius","oai_identifier":"oai:vu.lt:elaba:211844827"},"canonical_url":"https://search.ndltd.org/etd/vilnius/oai:vu.lt:elaba:211844827","repository":{"repo_id":"vilnius","name":"Vilnius University","base_url":"https://epublications.vu.lt/oai"},"display":{"title":"Chemoterapijos įtaka pooperacinei kepenų regeneracijai /","abstract":"Colorectal cancer is the third most common oncological disease contributing to patient mortality. Due to improved diagnostics and preventive programs, the 5-year survival rate of patients has significantly increased, reaching 90%. However, metastatic liver disease greatly worsens patients' quality of life and survival rates. Unfortunately, about 15-20% of patients already have liver metastases at the time of diagnosis, and during treatment, 20-50% of patients will develop them. With the advent of modern liver surgery techniques combined with chemotherapy, the 5-year survival rate of patients with stage IV colorectal cancer with liver metastases has increased to 50%. The primary factor limiting the extent of liver resection is the postoperative liver volume, as inadequate volume can lead to liver failure, raising postoperative mortality to 80%. This doctoral dissertation analyses the treatment outcomes of colorectal cancer by comparing postoperative results in patients undergoing liver resection, considering chemotherapy treatment and the predicted residual liver volume. The study evaluates the dynamics of liver regenerative markers in the serum and their expression in histological images, assesses liver function in the postoperative period, examines the influence of liver regenerative markers on postoperative liver regeneration, and reviews the short- and long-term results of liver metastasis in patients treated at Vilnius University Hospital Santaros Clinics (VULSK).","abstract_html":"Colorectal cancer is the third most common oncological disease contributing to patient mortality. Due to improved diagnostics and preventive programs, the 5-year survival rate of patients has significantly increased, reaching 90%. However, metastatic liver disease greatly worsens patients&#x27; quality of life and survival rates. Unfortunately, about 15-20% of patients already have liver metastases at the time of diagnosis, and during treatment, 20-50% of patients will develop them. With the advent of modern liver surgery techniques combined with chemotherapy, the 5-year survival rate of patients with stage IV colorectal cancer with liver metastases has increased to 50%. The primary factor limiting the extent of liver resection is the postoperative liver volume, as inadequate volume can lead to liver failure, raising postoperative mortality to 80%. This doctoral dissertation analyses the treatment outcomes of colorectal cancer by comparing postoperative results in patients undergoing liver resection, considering chemotherapy treatment and the predicted residual liver volume. The study evaluates the dynamics of liver regenerative markers in the serum and their expression in histological images, assesses liver function in the postoperative period, examines the influence of liver regenerative markers on postoperative liver regeneration, and reviews the short- and long-term results of liver metastasis in patients treated at Vilnius University Hospital Santaros Clinics (VULSK).","abstract_has_math":false,"creators":["Račkauskas, Rokas,"],"institution":"Institutional Repository of Vilnius University","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Strupas, Kęstutis"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024","date_published":"2024","updated_at":"2026-11-19T09:42:53Z","subjects":["Regeneration ; chemotherapy ; resection ; liver volume"],"languages":["lit"],"rights":["info:eu-repo/semantics/openAccess"],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://repository.vu.lt/VU:ELABAETD211844827&prefLang=en_US","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://repository.vu.lt/VU:ELABAETD211844827&prefLang=en_US","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":"open","embargo_until":null,"access_note":null},"source_record":{"url":"https://epublications.vu.lt/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Avu.lt%3Aelaba%3A211844827","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Strupas, Kęstutis"]},{"key":"dc:creator","label":"Author","values":["Račkauskas, Rokas,"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2024"]},{"key":"dc:publisher","label":"Institution","values":["Institutional Repository of Vilnius University"]},{"key":"dc:relation","label":"Dc Relation","values":["info:eu-repo/semantics/altIdentifier/doi/10.15388/vu.thesis.683","https://epublications.vu.lt/object/elaba:211844827/211844827.pdf"]},{"key":"dc:type","label":"Dc Type","values":["info:eu-repo/semantics/doctoralThesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Regeneration ; chemotherapy ; resection ; liver volume"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["lit"]},{"key":"dc:rights","label":"Dc Rights","values":["info:eu-repo/semantics/openAccess"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://repository.vu.lt/VU:ELABAETD211844827&prefLang=en_US"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Colorectal cancer is the third most common oncological disease contributing to patient mortality. Due to improved diagnostics and preventive programs, the 5-year survival rate of patients has significantly increased, reaching 90%. However, metastatic liver disease greatly worsens patients' quality of life and survival rates. Unfortunately, about 15-20% of patients already have liver metastases at the time of diagnosis, and during treatment, 20-50% of patients will develop them. With the advent of modern liver surgery techniques combined with chemotherapy, the 5-year survival rate of patients with stage IV colorectal cancer with liver metastases has increased to 50%. The primary factor limiting the extent of liver resection is the postoperative liver volume, as inadequate volume can lead to liver failure, raising postoperative mortality to 80%. This doctoral dissertation analyses the treatment outcomes of colorectal cancer by comparing postoperative results in patients undergoing liver resection, considering chemotherapy treatment and the predicted residual liver volume. The study evaluates the dynamics of liver regenerative markers in the serum and their expression in histological images, assesses liver function in the postoperative period, examines the influence of liver regenerative markers on postoperative liver regeneration, and reviews the short- and long-term results of liver metastasis in patients treated at Vilnius University Hospital Santaros Clinics (VULSK)."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Chemoterapijos įtaka pooperacinei kepenų regeneracijai /","Impact of Chemotherapy on Postoperative Liver Regeneration."]}]}],"canonical_facts":{"dc:contributor":["Strupas, Kęstutis"],"dc:creator":["Račkauskas, Rokas,"],"dc:date":["2024"],"dc:description":["Colorectal cancer is the third most common oncological disease contributing to patient mortality. Due to improved diagnostics and preventive programs, the 5-year survival rate of patients has significantly increased, reaching 90%. However, metastatic liver disease greatly worsens patients' quality of life and survival rates. Unfortunately, about 15-20% of patients already have liver metastases at the time of diagnosis, and during treatment, 20-50% of patients will develop them. With the advent of modern liver surgery techniques combined with chemotherapy, the 5-year survival rate of patients with stage IV colorectal cancer with liver metastases has increased to 50%. The primary factor limiting the extent of liver resection is the postoperative liver volume, as inadequate volume can lead to liver failure, raising postoperative mortality to 80%. This doctoral dissertation analyses the treatment outcomes of colorectal cancer by comparing postoperative results in patients undergoing liver resection, considering chemotherapy treatment and the predicted residual liver volume. The study evaluates the dynamics of liver regenerative markers in the serum and their expression in histological images, assesses liver function in the postoperative period, examines the influence of liver regenerative markers on postoperative liver regeneration, and reviews the short- and long-term results of liver metastasis in patients treated at Vilnius University Hospital Santaros Clinics (VULSK)."],"dc:format":["application/pdf"],"dc:identifier":["https://repository.vu.lt/VU:ELABAETD211844827&prefLang=en_US"],"dc:language":["lit"],"dc:publisher":["Institutional Repository of Vilnius University"],"dc:relation":["info:eu-repo/semantics/altIdentifier/doi/10.15388/vu.thesis.683","https://epublications.vu.lt/object/elaba:211844827/211844827.pdf"],"dc:rights":["info:eu-repo/semantics/openAccess"],"dc:subject":["Regeneration ; chemotherapy ; resection ; liver volume"],"dc:title":["Chemoterapijos įtaka pooperacinei kepenų regeneracijai /","Impact of Chemotherapy on Postoperative Liver Regeneration."],"dc:type":["info:eu-repo/semantics/doctoralThesis"]},"updated_at":"2026-11-19T09:42:53Z"}